Biopharmaceutical
Pharmaceutical
Health

AbbVie

$80.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.09 (-1.34%) Today
+$0.51 (0.64%) After Hours

Why Robinhood?

You can buy or sell AbbVie and other stocks, options, ETFs, and crypto commission-free!

About

ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. Read More The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.

Employees
30,000
Headquarters
North Chicago, Illinois
Founded
2013
Market Cap
118.35B
Price-Earnings Ratio
22.94
Dividend Yield
4.28
Average Volume
6.59M
High Today
$81.10
Low Today
$79.87
Open Price
$81.09
Volume
1.16M
52 Week High
$103.16
52 Week Low
$75.62

Collections

Biopharmaceutical
Pharmaceutical
Health
Manufacturing
Cancer Prevention
Technology
2013 IPO
US

News

Yahoo FinanceMay 24

Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates

The biggest news this week was Merck’s MRK offer to buy small cancer biotech Peloton Therapeutics, which will add a late-stage kidney cancer candidate to its oncology pipeline.

17
Yahoo FinanceMay 22

Top Ranked Income Stocks to Buy for May 22nd

Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 22nd: The Buckle, Inc. (BKE): This retailer of casual apparel, footwear and accessories has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.1% over the last 60 days. Buckle, Inc. (The) Price and Consensus Scroll to continue with content Ad Buckle, Inc. (The) Price and Consensus Buckle, Inc. (The) price-consensus-chart | Buckle, Inc. (The) Quote This Zacks Rank #1...

3
Yahoo FinanceMay 21

Better Buy: AbbVie vs. Pfizer

Over the last five years, AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) have both produced market-crushing returns for investors -- that is, when their top-notch dividends are figured into the equation.

125

Earnings

$1.38
$1.63
$1.89
$2.14
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 26, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.